Literature DB >> 284782

Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia.

J M Trujillo, A Cork, M J Ahearn, E L Youness, K B McCredie.   

Abstract

Cytogenetic studies were performed in 546 patients with acute leukemia between 1968 and 1975. Two hundred thirty-four patients were aneuploid (42.9%), and 312 patients were diploid (57.1%). Among these, 32 patients were found to exhibit similar chromosomal alterations that appeared to involve specifically chromosomes 8 and 21. Banding studies in at least 15 of these patients confirmed the presence of a translocation between these two chromosomes. The cytogenetic findings were correlated with the hematologic and clinical data. It was found that each of these individuals had a typical picture of acute granulocytic leukemia with Auer rod-positive and peroxidase-positive cells. Ultrastructurally, the patients in this group also consistently demonstrated the presence of a nuclear bleb that has been positively associated with aneuploidy in acute leukemia. Clinically, they seemed to respond better to therapy than other adult patients with acute granulocytic leukemia. It is proposed that the 8/21 translocation acute leukemia represents a definite subgroup within the general category of acute granulocytic leukemia, with an incidence of approximately 7.3%.

Entities:  

Mesh:

Year:  1979        PMID: 284782

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.

Authors:  Peter H Wiernik
Journal:  Med Oncol       Date:  2014-07-22       Impact factor: 3.064

2.  Clinical and prognostic investigations on M2/t(8;21) acute nonlymphocytic leukemia.

Authors:  F J Cheng; A D Yang; H B Fei; H Tian
Journal:  J Tongji Med Univ       Date:  1993

3.  Significance of chromosomal studies in leukemia: karyotype analysis of 28 cases of leukemia and 2 cases of myelofibrosis.

Authors:  A Yang; S M Liu; J Yan; H G Fei; B M Wang; J Guo; S Y Zhu
Journal:  Acta Acad Med Wuhan       Date:  1981

4.  Cytogenetic study in acute myelocytic leukemia M2.

Authors:  S M Liu; A D Yang; J Yan; H B Fei; M J He; B M Wang
Journal:  Acta Acad Med Wuhan       Date:  1984

5.  Therapeutic modalities for central nervous system involvement by granulocytic sarcoma (chloroma) in children with acute nonlymphocytic leukemia.

Authors:  Y Takaue; S J Culbert; T Baram; A Cork; J M Trujillo
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

6.  A subtype of the prototypic karyotype in acute myeloid leukemia t (8; 21) (q22; q22), del 9 (q13; q23).

Authors:  D K Hossfeld; M Higi; S Köhler; A Miller; R Zschaber
Journal:  Blut       Date:  1980-01

7.  Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.

Authors:  M Talpaz; Z Estrov; H Kantarjian; S Ku; A Foteh; R Kurzrock
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

8.  Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML).

Authors:  H J Weh; R Kuse; R Hoffmann; D Seeger; S Suciu; H Kabisch; J Ritter; D K Hossfeld
Journal:  Blut       Date:  1988-01

9.  Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).

Authors:  Akihiro Abe; Yukiya Yamamoto; Akira Katsumi; Akinao Okamoto; Masutaka Tokuda; Yoko Inaguma; Kiyoko Yamamoto; Masamitsu Yanada; Tadaharu Kanie; Akihiro Tomita; Yoshiki Akatsuka; Masataka Okamoto; Toshiki Kameyama; Akila Mayeda; Nobuhiko Emi
Journal:  Int J Hematol       Date:  2017-12-20       Impact factor: 2.490

10.  A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22).

Authors:  Keiki Kawakami; Kazuhiro Nishii; Ryuu Hyou; Yasuyuki Watanabe; Makoto Nakao; Hidetsugu Mitani; Tetsuya Murata; Fumihiko Monma; Shunji Yamamori; Noboru Hosokai; Ikuo Miura
Journal:  Int J Hematol       Date:  2007-11-27       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.